drugset / Trial / NCT00178113

A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia

NCT00178113

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether dietary lycopene supplementation lowers serum prostate specific antigen(PSA) in men with high grade intraepithelial neoplasia (HGPIN).

Timeline

Start
2003-07
Primary completion
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Lycopene Other / unclassified 30 mg
Background Certagen Unknown